Product Images Milrinone Lactate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Milrinone Lactate NDC 71288-200 by Meitheal Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - mil02 0002 01

Chemical Structure - mil02 0002 01

Principal Display Panel – 10 mg per 10 mL Vial Label - mil02 0002 02

Principal Display Panel – 10 mg per 10 mL Vial Label - mil02 0002 02

This is a drug called Milrinon Lactate Injection, used for intravenous use only. It comes in a 10mL single-dose vial with a strength of 10mg per 10mL, which means 1mg per mL. The drug is manufactured by Meitheal Pharmaceuticals for the US market. There are also alphanumeric codes that could be related to its production and quality control.*

Principal Display Panel – 10 mg per 10 mL Carton - mil02 0002 03

Principal Display Panel – 10 mg per 10 mL Carton - mil02 0002 03

This is a description of a medication called Milrinone Lactate Injection, which is designed for intravenous use only. Each 1 mL of the solution contains Mirinone Bctate equivalent to 1 mg Mirinone and 47 mg of Dextrose Anhydrous. The solution is to be used in its entirety after an initial use, and the unused portion discarded. The medication must be stored at a temperature range of 20°C to 25°C to avoid freezing. Each box contains 10 single-dose vials of 10 mL each.*

Principal Display Panel – 20 mg per 20 mL Vial Label - mil02 0002 04

Principal Display Panel – 20 mg per 20 mL Vial Label - mil02 0002 04

Principal Display Panel – 20 mg per 20 mL Carton - mil02 0002 05

Principal Display Panel – 20 mg per 20 mL Carton - mil02 0002 05

Milrinone Lactate Injection is a type of medication used for intravenous use only. The usual dosage should be followed according to the package insert. Each ml contains milrinone lactate that is equivalent to 1 mg of milrinone and 47 mg of Dextrose Anhydrous. The solution contains lactic acid or sodium hydroxide that has a pH adjusted between 3.2 and 4.0. The total concentration of lactic acid can vary between 0.95 mg per mL and 1.29 mg per mL. Milrinone Lactate Injection is a preservative-free solution that should not be frozen and should be stored at 20°C to 25°C. The container closure of this medication is not made with natural rubber latex. NDC 7128820021 is the number given to this medication. The available size is 1020 mL single-dose vials.*

Principal Display Panel – 50 mg per 50 mL Vial Label - mil02 0002 06

Principal Display Panel – 50 mg per 50 mL Vial Label - mil02 0002 06

Milrinone Lactate Injection, USP is an intravenous medication manufactured by Meitheal Pharmaceuticals in the USA. The medication has an NDC code of 71288-200-50 and is supplied in a single-dose 50 mL vial containing 50 mg of the medication per 50 mL (1 mg/mL). The medication is used for intravenous use only.*

Principal Display Panel – 50 mg per 50 mL Carton - mil02 0002 07

Principal Display Panel – 50 mg per 50 mL Carton - mil02 0002 07

This is a product description of Milrinone Injection, USP used for intravenous use only. It is available in a 50 mL single-dose vial with a concentration of 0.85 mg/ml Milrinone and 47 mg/ml lactate. The pH of the solution is adjusted between 3.2 and 4.0 using acetic acid or sodium hydroxide. This product should be stored at 20°C to 25°C and should be discarded after single use. The product has no preservatives and is free of natural rubber latex. This product is manufactured by Meitheal Pharmaceuticals, located in Chicago, IL.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.